Breast Cancer Now 2024: 5 Startups Empowering Breast Cancer Patients

The Breast Cancer Now fashion show recently took place in central London, showcasing the strength and resilience of 24 individuals living with or beyond breast cancer. This annual event, organised by Breast Cancer Now, the UK’s largest breast cancer charity, provides a platform for individuals to celebrate their journey and reflect on their experiences with the disease.

TV presenter Lisa Snowdon hosted the event, who is also a longstanding ambassador for the charity. She emphasised the importance of early detection and seeking medical help, and highlighted the courage and positivity of the models who confidently strutted down the catwalk, inspiring others with their stories.

It’s crucial to recognise the support available to those affected by breast cancer amidst the celebration of strength and courage. Startups and organisations like Breast Cancer Now offer valuable resources and assistance to victims and survivors, ensuring they receive the care and support they need throughout their journey.

Latest Breast Cancer Statistics

According to Cancer Research UK, the latest statistics on breast cancer in the UK reveal that around 55,900 new cases are diagnosed each year, translating to over 150 cases daily. Breast cancer remains the most common cancer in the UK, comprising 15% of all new cancer cases. Although breast cancer is more prevalent in females, affecting approximately 55,500 women annually, it’s not among the 20 most common cancers in males, with about 370 new cases yearly.

While breast cancer incidence rates have risen since the early 1990s, particularly among females, mortality rates have decreased significantly by around two-fifths since the early 1970s. These statistics prove the importance of ongoing research, early detection, and access to effective treatments in combating breast cancer.

Startups Empowering Breast Cancer Patients

Breast cancer can be a challenging and difficult experience for patients and survivors. However, there are startups that are dedicated to helping and supporting them. These innovative companies offer a wide range of services, from emotional support to practical assistance, aimed at empowering individuals affected by breast cancer. 

Through their dedication, these startups contribute significantly to the broader effort of creating resilience and improving outcomes for breast cancer patients.

MammoCheck

MammoCheck empowers women to take control of their breast health with convenient at-home monitoring. Their easy-to-use kits provide real-time breast health monitoring, offering accurate results within minutes.

With breast cancer being a global concern, MammoCheck aims to increase early detection rates, improving the chances of successful treatment and long-term survival. Users can order their kit online, perform the examination at home, and receive detailed reports, all from the comfort of their own home.

Gabbi

Gabbi provides personalised breast cancer risk assessments and virtual appointments with breast health specialists, offering same-day or next-day care. Their easy-to-use platform allows users to book appointments, order tests, and receive ongoing support, all from the comfort of home.

With a team of experienced healthcare professionals, Gabbi aims to empower individuals to take control of their breast health, offering timely interventions to catch cancer sooner.

Endomag

Endomag is a global leader in breast cancer treatment technology, offering sophisticated solutions for surgery. Developed from research at University College London and the University of Houston, their platform aims to improve surgical outcomes and make treatments accessible.

Trusted by over 1,000 hospitals in 45 countries, Endomag’s mission is to prevent unnecessary surgeries, improve outcomes, and make better care accessible worldwide.

OncoGenomX

OncoGenomX offers PredictionStar, the first predictive therapy decision support tool for breast cancer physicians and patients. It analyses tumor-specific genomic, biological, and clinical information to guide evidence-based therapy decisions. PredictionStar aims to empower optimal therapies with predictable outcomes, all while being cost-effective and neutral for healthcare budgets.

Their team of industry experts ensures continuous improvement and widespread adoption, making PredictionStar a vital tool in breast cancer treatment.

Hera-MI

Hera-MI, a French startup, offers Breast-SlimView, an AI-based breast cancer diagnosis solution.

The patented software aids radiologists in analysing mammograms more efficiently by automatically detecting normal physiological areas and masking healthy breast tissue. This process, known as “negativation,” allows radiologists to focus more on complex areas, reducing time spent on non-problematic ones.

CE-certified, Breast-SlimView is available in Europe, the Middle East, and North Africa, streamlining clinical decision-making in breast cancer diagnosis.